Even more strikingly, liver specific CRISPR/Cas9-mediated p85α knockdown in vivo, using hydrodynamic injection, drastically reduced HCC development in mice stably overexpressing ChREBP in hepatocytes (Fig. 4g). Here, MLXIPL is linked to hepatocellular carcinoma.